Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is one of six main centers for the U.S. Food and Drug Administration, which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Peter Marks, M.D., PhD. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Center for Biologics Evaluation and Research, United States, covering academic research published from 2000 to 2021. Read More.
Open Access Percentage
60%
Total
Publications
3.7K
Total Open
Publications
2.2K
Total
Citations
149K
Open Access
Percentage
60%
Total
Publications
3.7K
Total Open
Publications
2.2K
Total
Citations
149K
Breakdown
Publisher Open
13%
Both
30%
Other Platform Open
17%
Closed
40%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
618
Hybrid 22%
339
No Guarantees 39%
606
Other Platform Open
Domain 95%
1.6K
Public 14%
239
Institution 12%
206
Preprint 6%
97
Other Internet 5%
78
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.6K |
Europe PMC | Domain | 1.4K |
Semantic Scholar | Public | 220 |
MDPI | Preprint | 47 |
CiteSeer X | Other Internet | 37 |
bioRxiv | Preprint | 35 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 34 |
DOI | Other Internet | 26 |
Zenodo | Public | 15 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Other Internet | 15 |